Navigation Links
Non-Hormonal Therapies Aid Breast Cancer Patients
Date:12/9/2008

This applies to women with metastatic or recurrent inoperable disease, report says

TUESDAY, Dec. 9 (HealthDay News) -- Over the last 35 years, non-hormonal treatments have improved overall survival of patients with advanced breast cancer.

So say Greek researchers who conducted a review of 128 clinical trials that included more than 26,000 women with the disease.

The review showed that use of anthracycline regimens led to a 22 percent relative risk reduction in overall death, compared with older single-agent chemotherapy. Single drug taxane treatment led to a relative risk reduction of 33 percent, while a combination of a taxane with capecitabine or gemcitabine led to a 51 percent relative risk reduction over single-agent chemotherapy.

Most of the regimens appeared to be effective whether or not women had received a prior treatment.

"Our meta-analysis quantifies the progress achieved in the treatment of advanced breast cancer with nonhormonal systemic treatment in the last 35 years. Several regimens have shown effectiveness, and for some of them, the treatment effects are practically indistinguishable in magnitude," the review authors wrote. "Given that subsequent lines of treatment can confer similar relative benefits as the first-line setting, one can exploit the survival benefits conferred by several effective regimens used in sequential fashion."

The study was published Dec. 9 in the Journal of the National Cancer Institute.

This review is important because there has been no consensus regarding the best dosage, timing, sequence or combination of therapies for treatment of metastatic breast cancer, due to the fact that standard comparators haven't been available, Dr. Philippe Bedard and Dr. Martine Piccart-Gebhart, of the Jules Bordet Institute in Brussels, Belgium, wrote in an accompanying editorial.

The finding that many of the regimens have similar relative effec
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Bogus Stem Cell Therapies Sold on Internet
2. Market for Cellular Therapies Will Grow at a Robust Annual Rate of More Than 30 Percent in the United States Through 2017
3. Non-white med students reject therapies associated with their culture
4. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
5. Stem cell therapies for heart disease -- 1 step closer
6. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
7. Study shows steroid therapies following transplant can be eliminated
8. Study Evaluates Laser Therapies for Hair Removal
9. New Journal to Explore Neurodegenerative, Neuroprotective and Euroregenerative Therapies!
10. New way to control protein activity could lead to cancer therapies
11. Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... 101 Mobility® is a leading nationwide ... accessibility solutions for both consumer and commercial applications. ... ramps, vertical platform lifts, vehicle lifts for mobility ... elevators, among others. 101 Mobility operates over 30 ...
(Date:5/24/2013)... May 2013, Paris, France: Routinely measuring fractional flow ... angiography for diagnosis of chest pain leads to ... four patients, according to results from a study ... routine pressure wire assessment influence management strategy at ... was designed to assess whether routine assessment of ...
(Date:5/24/2013)... Beach Gardens, FL (PRWEB) May 24, 2013 ... surgeons jealous, Dr. Greg DeLange of the Estetica ... of the hosts of KOOL 105.5 FM’s popular morning show, ... the air about their experiences and their satisfaction with the ... Institute, a cutting-edge facility located in Palm Beach Gardens, very ...
(Date:5/24/2013)... 24, 2013 Electric™ Energy Straws, an exciting ... Rookie Carlos Munoz and will be the lead sponsor on ... the Indianapolis Motor Speedway. Munoz, who is part of Andretti ... 228.342 mph in race, qualifying to be named the 2013 ... row in Sunday’s race. , While Munoz is grabbing ...
(Date:5/24/2013)... 24, 2013 General Data Company ... identification, tracking and data management products and solutions, ... Sciences Inc., (TBS) of Durham, North Carolina, a ... consumables for the clinical and research pathology marketplace. ... Healthcare, which provides specialty products and solutions to ...
Breaking Medicine News(10 mins):Health News:Cortec Closes Equity Transaction with 101 Mobility 2Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3
... Minutes after Elizabeth Edwards was presented with NHPCO,s Person ... podium to look at her notes as a shout came ... brightened her face as the audience of 1,600 broke out ... optimism that was reinforced by Edwards, remarks.Edwards received NHPCO,s Person ...
... 7 Ziehm Imaging, a provider of mobile ... of software-driven systems for targeted, less-invasive medical treatments, ... marketing agreement for the integration of mobile 3D ... Imaging and BrainLAB jointly pioneered the development of ...
... in certain areas, researchers say , , THURSDAY, May 7 ... stimulation improved symptoms and, in some cases, launched a ... suffered for decades and who had failed multiple other ... had depression for 27 years and had failed about ...
... shows that Wild Blueberries may have a cardio-protective effect, ... vessels to oxidative stress. (Sources: Journal of Medicinal ... of Nutritional Biochemistry , 2009, Jan 19) The studies ... potential protective effect of Wild Blueberries in the diet ...
... May 7 Celebrity cook Paula Deen has ... the safety of pork since the H1N1 flu ... is speaking out.To view the Multimedia News Release, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090507/NY13156 )"You know y,all, ...
... 7 Conseco, Inc. (NYSE: CNO ) ... that its subscribers who hold Conseco, Inc. stock vote ... for a dissident nominee for the ninth director up ... its recommendation to elect a dissident at Conseco,s upcoming ...
Cached Medicine News:Health News:Elizabeth Edwards Presented With Person of the Year Award by National Hospice and Palliative Care Organization at National Conference 2Health News:Ziehm Imaging and BrainLAB Extend Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) to North America 2Health News:Ziehm Imaging and BrainLAB Extend Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) to North America 3Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 2Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 3Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 4Health News:New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health 2Health News:New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health 3Health News:Video: Paula Deen Calls on America to Reject Myths, Misinformation; Enjoy a Pork Chop Tonight 2
(Date:5/23/2013)...   Direct to implant, or "one step," ... option for many women with BRCA (BReast CAncer) ... cancer risk, or with breast cancer. Traditionally, post-mastectomy ... second surgery to insert permanent implants, but immediate ... mastectomy can be a medically and cosmetically effective ...
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress Solutions, ... market, announced today the company has signed a letter ... company based in Huntsville, AL . ... in the staffing and recruitment of telemedicine physicians. Consideration ... the final agreement, which is expected by June 30, ...
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Taiho Pharmaceutical Co., Ltd. announced on May 31 ... the novel combination antimetabolite TAS-102 will start in June ... double-blind, placebo-controlled Phase III trial that compares TAS-102 with ... safety of TAS-102 when administered to patients with advanced ...
...  Today, at the 52nd annual New Clinical Drug Evaluation ... of Psychiatry at the University of California, Los Angeles ... presented the results from the first 6-subject cohort of ... effects of external trigeminal nerve stimulation (eTNS™) on Post-Traumatic ...
Cached Medicine Technology:Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 2Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 2Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 4Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: